TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive Research Contract Dollars Will Drop In 1980, But Will Increase Sharply for Some Programs July 7, 1978
TCL Archive ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market September 26, 1997
